Education
About Us
Working with TipRanks
Follow Us
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD)
ASX:RMD
RESEARCH TOOLSreports
RMD Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$27.05 - AU$40.75
Previous CloseN/A
Volume1.29M
Average Volume (3M)1.48M
Market Cap
AU$50.95B
Enterprise ValueAU$54.74B
Total Cash (Recent Filing)$210.25M
Total Debt (Recent Filing)$1.39B
Price to Earnings (P/E)26.8
Beta0.85
Next Earnings
Apr 23, 2025EPS Estimate
0.38Last Dividend Ex-Date
Feb 12, 2025Dividend Yield0.92%
Share Statistics
EPS (TTM)1.28
Shares Outstanding1,468,669,100
10 Day Avg. Volume1,763,709
30 Day Avg. Volume1,476,876
Financial Highlights & Ratios
PEG Ratio0.65
Price to Book (P/B)N/A
Price to Sales (P/S)5.69
Price to Cash Flow (P/CF)22.30
P/FCF Ratio22.30
Enterprise Value/Market Cap1.07
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit20.62
Enterprise Value/Ebitda31.27
Forecast
1Y Price Target
AU$44.53Price Target Upside27.85% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10
---
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh News
PremiumCompany Announcements
ResMed Inc. Officer Plans to Sell Shares Under Rule 144---
Bulls Say, Bears Say
Bulls Say
Financial HealthShare buybacks worth US$75 million were executed during the quarter, which can signal confidence in the company's financial health.
Market OpportunitiesThere is no clarity on Philips’ return to the US market, which may benefit RMD in the short term.
Valuation And GrowthUpgrade to Buy on reasonable valuation, strong EPS growth, FCF, and no debt by FY end.
Bears Say
Patient GrowthHealthcare systems’ capacity constraints will likely keep a lid on new patients growth.
Revenue PerformanceRevenue from the Rest of World masks and SaaS was below consensus, indicating some areas of underperformance.
Valuation ConcernsDespite strong performance, the valuation of the stock is already considered to be priced in, limiting upside potential.
---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
<0.01%
Mutual Funds
<0.01% Other Institutional Investors
99.99% Public Companies and
Individual Investors
RMD FAQ
What was Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s price range in the past 12 months?
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh lowest share price was AU$27.05 and its highest was AU$40.75 in the past 12 months.
What is Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s market cap?
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s market cap is AU$50.95B.
When is Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s upcoming earnings report date?
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s upcoming earnings report date is Apr 23, 2025 which is in 11 days.
How were Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s earnings last quarter?
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh released its earnings results on Jan 30, 2025. The company reported AU$0.39 earnings per share for the quarter, beating the consensus estimate of AU$0.372 by AU$0.018.
Is Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh overvalued?
According to Wall Street analysts Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s price is currently Undervalued.
Does Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh pay dividends?
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh pays a Annually dividend of AU$0.317 which represents an annual dividend yield of 0.92%. See more information on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh dividends here
What is Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s EPS estimate?
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s EPS estimate is 0.38.
How many shares outstanding does Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh have?
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh has 1,468,669,100 shares outstanding.
What happened to Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s price movement after its last earnings report?
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh reported an EPS of AU$0.39 in its last earnings report, beating expectations of AU$0.372. Following the earnings report the stock price went down -0.792%.
Which hedge fund is a major shareholder of Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh?
Currently, no hedge funds are holding shares in AU:RMD
---
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
AU$44.53 (27.85% Upside)
AU$44.53 (27.85% Upside)
Blogger Sentiment
Bullish
AU:RMD Sentiment 94%
Sector Average 69%
Sector Average 69%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
20.65%
12-Months-Change
Fundamentals
Return on Equity
25.16%
Trailing 12-Months
Asset Growth
13.98%
Trailing 12-Months
Company Description
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
---
RMD Revenue Breakdown
88.21% Sleep and Respiratory Care
11.79% Software as a Service
---
RMD Stock 12 Month Forecast
Average Price Target
AU$44.53
▲(27.85% Upside)
Technical Analysis
Best Analysts Covering RMD
1 Year
1 Year Success Rate
6/11 ratings generated profit
1 Year Average Return
+6.19%
reiterated a buy rating 2 months ago
Copying Steven Wheen's trades and holding each position for 1 Year would result in 54.55% of your transactions generating a profit, with an average return of +6.19% per trade.
---